Beta Bionics, Inc. Overview
BBNX market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
BBNX price chart · 1M
- O
- 17.15
- H
- 17.15
- L
- 14.55
- C
- 15.46
- Vol
- 90,134.00
Daily history from Jan 30, 2025
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $17.15
- Previous Close
- $16.94
- Day High
- $17.15
- Day Low
- $14.55
- 52 Week High
- $32.53
- 52 Week Low
- $8.81
- 7 Day Return
- -12.06%
- 30 Day Return
- -17.06%
- 90 Day Return
- -2.71%
- 1 Year Return
- -41.62%
- Daily Notional Volume
- $1.4M Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.81 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.89 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -61.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.80 – $32.71 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $864.4M · P/B 4.66 · P/S 7.26.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to an Upcoming Deadline of November 3, 2026 in the Securities Class ActionGlobenewswire Inc ·
8-K filing — Beta Bionics, Inc. (BBNX)SEC EDGAR ·
Jefferies Initiates Coverage On Beta Bionics with Buy Rating, Announces Price Target of $30Benzinga ·
BBNX Stockholders Have Rights – If You Lost Money Investing in Beta Bionics, Inc. Contact Robbins LLP for Information About Recovering Your LossesGlobenewswire Inc ·